Functionally differentiating two neuronal nitric oxide synthase isoforms through antisense mapping: Evidence for opposing NO actions on morphine analgesia and tolerance

Proceedings of the National Academy of Sciences of the United States of America

Volumn 94, Issue 15, 1997, Pages 8220-8225

  Kolesnikov, Yuri A ^a   Pan, Ying Xian ^a   Babey, Anna Marie ^a   Jain, Subash ^a   Wilson, Roger ^a   Pasternak, Gavril W ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

MOR 1; Nu receptor; Opioid

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; MESSENGER RNA; MORPHINE SULFATE; MU OPIATE RECEPTOR; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ALTERNATIVE RNA SPLICING; ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG TOLERANCE; ENZYME ACTIVITY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MOUSE; NEUROMODULATION; NEUROPHARMACOLOGY; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SUBCUTANEOUS DRUG ADMINISTRATION;

ANALGESIA; ANIMALS; DRUG TOLERANCE; ISOENZYMES; MALE; MICE; MORPHINE; NEURONS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROARGININE; OLIGONUCLEOTIDES, ANTISENSE;

ANIMALIA;

EID: 0030743849     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.94.15.8220     Document Type: Article

References (49)

1. Snyder, S. H. & Bredt, D. S. (1992) Sci. Am. 266, 68-77.
2. Snyder, S. H. & Bredt, D. S. (1991) Trends Pharmacol. Sci. 12, 125-128.
3. Dawson, T. M. & Dawson, V. L. (1994) Neuroscientist 1, 9-20.
4. Nathan, C. & Xie, Q.-W. (1994) J. Biol. Chem. 269, 13725-13728.
5. Bredt, D. S. & Snyder, S. H. (1992) Neuron 8, 3-11.
6. Lovick, T. A. & Key, B. J. (1996) Exp. Brain Res. 108, 382-388.
7. Meller, S. T. & Gebhart, G. F. (1993) Pain 52, 127-136.
8. Duarte, I. D. G., Lorenzetti, B. B. & Ferreira, S. H. (1990) Eur. J. Pharmacol. 186, 289-293.
9. Gaffen, Z., Bland-Ward, P. A., Pitcher, A., Wallace, P. & Moore, P. K. (1994) Eur. J. Pharmacol. 271, 445-452.
10. Handy, R. L. C., Wallace, H. P., Gaffen, Z. A., Whitehead, K. J. & Moore, P. K. (1995) Br. J. Pharmacol. 116, 2349-2350.
11. Kolesnikov, Y. A., Pick, C. G. & Pasternak, G. W. (1992) Eur. J. Pharmacol. 221, 339-340.
12. Kolesnikov, Y. A., Pick, C. G., Ciszewska, G. & Pasternak, G. W. (1993) Proc. Natl. Acad. Sci. USA 90, 5162-5166.
13. London, E. D., Vaupel, D. B. & Kimes, A. S. (1994) Regul. Pept. 54, 165-166.
14. Babey, A. M., Kolesnikov, Y., Cheng, J., Inturrisi, C. E., Trifilletti, R. R. & Pasternak, G. W. (1994) Neuropharmacology 33, 1463-1470.
15. Pasternak, G. W., Kolesnikov, Y. A. & Babey, A. M. (1995) Neuropsychopharmacology 13, 309-313.
16. Vaupel, D. B., Kimes, A. S. & London, E. D. (1995) Neuropsychopharmacology 13, 315-322.
17. Dunbar, S. & Yaksh, T. L. (1996) Neurosci. Lett. 207, 33-36.
18. Bhargava, H. N. & Zhao, G. M. (1996) Neuropeptides 30, 219-223.
19. Adams, M. L., Kalicki, J. M., Meyer, E. L. & Cicero, T. J. (1993) Life Sci. 52, 245-249.
20. Trujillo, K. A. & Akil, H. (1994) Brain Res. 633, 178-188.
21. Trujillo, K. A. & Akil, H. (1991) Science 251, 85-87.
22. Elliott, K., Minami, N., Kolesnikov, Y. A., Pasternak, G. W. & Inturrisi, C. E. (1994) Pain 56, 69-75.
23. Gutstein, H. B. & Trujillo, K. A. (1993) Brain Res. 626, 332-334.
24. Kolesnikov, Y. A., Ferkany, J. & Pasternak, G. W. (1993) Life Sci. 53, 1489-1494.
25. Kolesnikov, Y. A., Maccechini, M.-L. & Pasternak, G. W. (1994) Life Sci. 55, 1393-1398.
26. Ben-Eliyahu, S., Marek, P., Vaccarino, A. L., Mogil, J. S., Sternberg, W. F. & Liebeskind, J. C. (1992) Brain Res. 575, 304-308.
27. Tiseo, P. & Inturrisi, C. E. (1993) J. Pharmacol. Exp. Ther. 264, 1090-1096.
28. Lutfy, K., Shen, K.-Z., Kwon, I.-S., Cai, S. X., Woodward, R. M., Keana, J. F. W. & Weber, E. (1995) Eur. J. Pharmacol. 273, 187-189.
29. Dunbar, S. & Yaksh, T. L. (1996) Anesthesiology 84, 1177-1188.
30. Bredt, D. S., Hwang, P. M., Glatt, C. E., Lowenstein, C., Reed, R. R. & Snyder, S. H. (1991) Nature (London) 351, 714-718.
31. Brenman, J. E., Chao, D. S., Gee, S. H., McGee, A. W., Craven, S. E., Santillano, D. R., Wu, Z., Huang, F., Xia, H., Peters, M. F., Froehner, S. C. & Bredt, D. S. (1996) Cell 84, 757-767.
32. Ogura, T., Yokoyama, T., Fujisawa, H., Kurashima, Y. & Esumi, H. (1993) Biochem. Biophys. Res. Commun. 193, 1014-1022.
33. Hall, A. V., Antoniou, H., Wang, Y., Cheung, A. H., Arbus, A. M., Olson, S. L., Lu, W. C., Kau, C.-L. & Marsden, P. A. (1994) J. Biol. Chem. 269, 33082-33090.
34. Wahlestedt, C. (1994) Trends Pharmacol. Sci. 15, 42-46.
35. Wagner, R. W. (1994) Nature (London) 372, 333-335.
36. Crooke, S. T. (1993) FASEB J. 7, 533-539.
37. Pasternak, G. W. & Standifer, K. M. (1995) Trends Pharmacol. Sci. 16, 344-350.
38. Pan, Y.-X., Cheng, J., Xu, J. & Pasternak, G. W. (1994) Regul. Pept. 54, 217-218.
39. Standifer, K. M., Chien, C.-C., Wahlestedt, C., Brown, G. P. & Pasternak, G. W. (1994) Neuron 12, 805-810.
40. Pan, Y.-X., Cheng, J., Xu, J., Rossi, G. C., Jacobson, E., Ryan-Moro, J., Brooks, A. I., Dean, G. E., Standifer, K. M. & Pasternak, G. W. (1995) Mol. Pharmacol. 47, 1180-1188.
41. Rossi, G. C., Standifer, K. M. & Pasternak, G. W. (1995) Neurosci. Lett. 198, 99-102.
42. Rossi, G. C., Pan, Y.-X., Brown, G. P. & Pasternak, G. W. (1995) FEBS Lett. 369, 192-196.
43. Haley, T. J. & McCormick, W. G. (1957) Br. J. Pharmacol. 12, 12-15.
44. D'Amour, F. E. & Smith, D. L. (1941) J. Pharmacol. Exp. Ther. 72, 174-179.
45. Dwyer, M. A., Bredt, D. S. & Snyder, S. H. (1991) Biochem. Biophys. Res. Commun. 176, 1136-1141.
46. Standifer, K. M., Jenab, S., Su, W., Chien, C.-C., Pan, Y.-X., Inturrisi, C. E. & Pasternak, G. W. (1995) J. Neurochem. 65, 1981-1987.
47. Standifer, K. M., Rossi, G. C. & Pasternak, G. W. (1996) Mol. Pharmacol. 50, 293-298.
48. Bredt, D. S., Glatt, C. E., Hwang, P. M., Fotuhi, M., Dawson, T. M. & Snyder, S. H. (1991) Neuron 7, 615-624.
49. Pasternak, G. W. (1993) Clin. Neuropharmacol. 16, 1-18.